PRCT MEXC RealStocks
Own real PRCT shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 07:18:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
PROCEPT BioRobotics Corporation (PRCT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $25.20, with a market capitalization of $1.37B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.67 to $38.11. This page covers its latest market performance, valuation, price trends and company information.
$1.37B | |
$23.66 | |
$25.82 | |
$23.37 | |
$23.78 | |
1.54M | |
1.30M | |
-- | |
$38.11 | |
$16.67 | |
-- | |
2026-09-30 |
PROCEPT BioRobotics Corporation (PRCT) last closed at $25.20 as of 2026-11-19 01:01:00, up 5.91% ($1.40) from the previous close of $23.78.
During the latest regular trading session, PRCT traded between $23.37 and $25.82, with a volume of 1.54M shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, PROCEPT BioRobotics Corporation (PRCT) moved from $23.05 to $25.20, representing a gain of 9.32% ($2.15).
The stock traded between $21.89 and $25.84 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.45 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 39.8%
PRCT is currently trading at $25.20, placing it 39.8% of the way from its 52-week low of $16.67 to its 52-week high of $38.11. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 888 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of PROCEPT BioRobotics Corporation (PRCT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PRCT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PRCT shares and USD.
PRCT Shares to USD
1.00 PRCT shares = 25.199 USD
Calculations are estimates based on the latest available price and are for reference only.